Skip to content

Quinlan Paul T

Reporting owner on Forms 3, 4 and 5, CIK 1333277.

Quinlan Paul T reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ORKA · Oruka Therapeutics, Inc.CIK 907654officer (General Counsel)22026-11-20

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-20M exercised+9,000$7.838,995Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-20S sold-3,300$94.048535,695Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-20S sold-3,000$94.773232,695Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-20S sold-2,500$95.994430,195Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-20S sold-200$96.629,995Form 4
ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative2026-11-20M exercised-9,000$061,996Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20M exercised+9,000$7.838,995Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20S sold-400$74.900738,595Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20S sold-500$76.11838,095Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20S sold-1,000$77.20537,095Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20S sold-4,100$78.789532,995Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-10-20S sold-3,000$79.491229,995Form 4
ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative2026-10-20M exercised-9,000$070,996Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0000907654-26-000120 Oruka Therapeutics, Inc.2026-11-20
Form 4 0000907654-26-000110 Oruka Therapeutics, Inc.2026-10-20